Cyrium Technologies, a developer of high efficiency multi-junction solar cells for concentrator photovoltaic systems, announced today that the firm has closed a Series B round of funding for a total of $15 million. Cyrium is a developer of innovative solutions in the solar renewable energy field. Cyrium’s solar cell technology significantly improves power generation while […]
Less
More
H2scan Corporation today announced the Company has secured $4 million in Series D funding. H2scan is the leading provider of high performance hydrogen specific sensor systems that provide accurate monitoring and control functions for a wide range of applications, including control systems, safety monitoring and alarm systems. H2scan also provides portable, hand-held configurations for easy […]
I Love Rewards Inc., a North American web-based corporate rewards and recognition firm, today announced that it has completed a $4.7 million Series A financing round. “People Drive Business. Incentives Drive People. I Love Rewards designs online points-based, branded corporate incentive programs that drive the behaviours most important to the success of your business”
Kickfire, Inc. today announced that it has closed a $20 mm series B financing. Kickfire provides the first high-performance, easy-to-use open source database appliance for the burgeoning MySQL market. Based on a patented SQL chip that packs the power of tens of CPUs into an exceptionally small, low-power form factor Kickfire delivers a quantum leap […]
Sierra Neuropharmaceuticals, Inc., a formulator of pharmaceuticals for direct-to-the-brain treatment of neurological diseases, announced a $21.5-million venture capital Series A financing. Sierra uses a proprietary drug development process that makes use of standard implantable pumps placed surgically under the skin which deliver drugs directly to the fluid around the brain via a catheter. The approach […]
Zogenix Inc. has secured an $18 million secured loan facility. Zogenix, Inc., with offices in Emeryville and San Diego, CA, is a private, specialty pharmaceutical company with two proprietary product candidates in late-stage development for the treatment of central nervous system (CNS) disorders and pain. The company’s lead product candidate, sumatriptan DosePro (previously Intraject), enables […]
Clickable, a New York-based provider of search advertising solutions, has raised $14.5 million in Series B funding. Clickable is an online solution that makes search advertising simple, instant and profitable. Clickable’s immediate activation and intuitive user experience make it easy for marketers to manage performance across all major search-ad networks, including Google, Yahoo and Microsoft. […]
Crescendo Networks, Ltd., the recognized performance leader in accelerating and optimizing Web applications, today announced the company has secured $9.5 million in its third round of major funding. Crescendo Networks is the recognized performance leader for accelerating and optimizing the delivery of business-critical, web-enabled applications. The company’s unique multi-tier application architecture dramatically improves the operation […]
CVRx, Inc., a private medical device company, has completed a fifth round of private equity financing totaling $84 million. The company has developed the Rheos® System, the only implantable device designed to control hypertension, or high blood pressure, a leading cause of heart and kidney disease, stroke and death. This device is intended to provide […]
Cytochroma Inc., a Markham, Ontario-based drug company focused on diseases and disorders related to vitamin D deficiency, has raised C$45 million ($43.4 mm) in Series C funding. Cytochroma is a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary products to treat and prevent the clinical consequences of vitamin D insufficiency and econdary […]
Misc Sectors